Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
3(27%)
Results Posted
33%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_1
2
18%
Ph not_applicable
4
36%
Ph phase_2
1
9%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
1(14.3%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(3)
Terminated(1)
Other(4)

Detailed Status

unknown4
Completed3
Recruiting3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (28.6%)
Phase 21 (14.3%)
N/A4 (57.1%)

Trials by Status

terminated19%
unknown436%
completed327%
recruiting327%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11